Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury - PubMed (original) (raw)
. 1999 Jan 1;14(2):109-14.
Affiliations
- PMID: 22387506
Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury
M Herrmann et al. Restor Neurol Neurosci. 1999.
Abstract
The present study aimed at the predictive value of early release patterns of protein S-100B and neuron specific enolase (NSE) in patients with traumatic brain injury. We investigated 69 patients who were admitted to the Department of Neurosurgery following traumatic brain injury. Both NSE and S-100B serum concentrations during the first three days after admission were highly and significantly correlated with Glasgow Coma and Coma Remission Scale scores at the respective blood sampling times as well as 2 weeks later. Signs of intracranial pathology as evaluated by CCT or MRI scans showed no association with NSE or S-100B release patterns. Our data support the hypothesis that NSE and protein S-100B are useful and sensitive neurobiochemical markers for the early clinical outcome of traumatic brain injury.
Similar articles
- Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury.
Herrmann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch CW. Herrmann M, et al. Restor Neurol Neurosci. 1999;14(2-3):109-114. Restor Neurol Neurosci. 1999. PMID: 12671254 - Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography.
Herrmann M, Jost S, Kutz S, Ebert AD, Kratz T, Wunderlich MT, Synowitz H. Herrmann M, et al. J Neurotrauma. 2000 Feb;17(2):113-22. doi: 10.1089/neu.2000.17.113. J Neurotrauma. 2000. PMID: 10709869 - [Serum S-100B protein and neuron-specific enolase after traumatic brain injury].
Sawauchi S, Taya K, Murakami S, Ishi T, Ohtsuka T, Kato N, Kaku S, Tanaka T, Morooka S, Yuhki K, Urashima M, Abe T. Sawauchi S, et al. No Shinkei Geka. 2005 Nov;33(11):1073-80. No Shinkei Geka. 2005. PMID: 16277220 Japanese. - Serum S-100B protein as a molecular marker in severe traumatic brain injury.
Raabe A, Kopetsch O, Woszczyk A, Lang J, Gerlach R, Zimmermann M, Seifert V. Raabe A, et al. Restor Neurol Neurosci. 2003;21(3-4):159-69. Restor Neurol Neurosci. 2003. PMID: 14530578 Review. - Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury.
Ingebrigtsen T, Romner B. Ingebrigtsen T, et al. Restor Neurol Neurosci. 2003;21(3-4):171-6. Restor Neurol Neurosci. 2003. PMID: 14530579 Review.
Cited by
- Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson's Disease.
Papuć E, Rejdak K. Papuć E, et al. Front Aging Neurosci. 2020 Jul 22;12:156. doi: 10.3389/fnagi.2020.00156. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32792937 Free PMC article. - A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke.
Berends AC, Luiten PG, Nyakas C. Berends AC, et al. CNS Drug Rev. 2005 Winter;11(4):379-402. doi: 10.1111/j.1527-3458.2005.tb00055.x. CNS Drug Rev. 2005. PMID: 16614737 Free PMC article. Review. - Blood-based diagnostics of traumatic brain injuries.
Mondello S, Muller U, Jeromin A, Streeter J, Hayes RL, Wang KK. Mondello S, et al. Expert Rev Mol Diagn. 2011 Jan;11(1):65-78. doi: 10.1586/erm.10.104. Expert Rev Mol Diagn. 2011. PMID: 21171922 Free PMC article. Review. - Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.
Thelin EP, Zeiler FA, Ercole A, Mondello S, Büki A, Bellander BM, Helmy A, Menon DK, Nelson DW. Thelin EP, et al. Front Neurol. 2017 Jul 3;8:300. doi: 10.3389/fneur.2017.00300. eCollection 2017. Front Neurol. 2017. PMID: 28717351 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Miscellaneous